JPS5758619A - Carcinostatic agent - Google Patents

Carcinostatic agent

Info

Publication number
JPS5758619A
JPS5758619A JP55133979A JP13397980A JPS5758619A JP S5758619 A JPS5758619 A JP S5758619A JP 55133979 A JP55133979 A JP 55133979A JP 13397980 A JP13397980 A JP 13397980A JP S5758619 A JPS5758619 A JP S5758619A
Authority
JP
Japan
Prior art keywords
agent
parenterally
daily
injection
active component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55133979A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6352608B2 (nl
Inventor
Setsuo Takeuchi
Mutsuyuki Kochi
Akira Kawarada
Shinichiro Esumi
Kazuya Sasaki
Tsuneo Saida
Masao Sakasai
Yukio Inoue
Tadasu Yamamoto
Ban Sanai
Takaharu Sekine
Koji Amamiya
Katsumasa Saga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
RIKEN Institute of Physical and Chemical Research
Original Assignee
Kaken Pharmaceutical Co Ltd
Kaken Chemical Co Ltd
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd, Kaken Chemical Co Ltd, RIKEN Institute of Physical and Chemical Research filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP55133979A priority Critical patent/JPS5758619A/ja
Publication of JPS5758619A publication Critical patent/JPS5758619A/ja
Publication of JPS6352608B2 publication Critical patent/JPS6352608B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP55133979A 1980-09-26 1980-09-26 Carcinostatic agent Granted JPS5758619A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55133979A JPS5758619A (en) 1980-09-26 1980-09-26 Carcinostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55133979A JPS5758619A (en) 1980-09-26 1980-09-26 Carcinostatic agent

Publications (2)

Publication Number Publication Date
JPS5758619A true JPS5758619A (en) 1982-04-08
JPS6352608B2 JPS6352608B2 (nl) 1988-10-19

Family

ID=15117543

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55133979A Granted JPS5758619A (en) 1980-09-26 1980-09-26 Carcinostatic agent

Country Status (1)

Country Link
JP (1) JPS5758619A (nl)

Also Published As

Publication number Publication date
JPS6352608B2 (nl) 1988-10-19

Similar Documents

Publication Publication Date Title
JPS5551020A (en) Remedy for rheumatism
JPS5630917A (en) Preventive and remedy for hepatitis
JPS5758626A (en) Carcinostatic agent
JPS5758619A (en) Carcinostatic agent
JPS57188520A (en) Antihyperkalemia
JPS5758618A (en) Carcinostatic agent
JPS5758620A (en) Carcinostatic agent
JPS5758621A (en) Carcinostatic agent
JPS57128625A (en) Carcinostatic
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS5793913A (en) Enhancing agent for spermous vital power
JPS57114519A (en) Antiarteriosclerotic agent
JPS54151134A (en) Antitumorigenic agent
JPS5536454A (en) Novel immunosuppressive agent
JPS5759809A (en) Cardiotonic agent
JPS54132239A (en) Anti-tumor agent
JPS5759808A (en) Remedy and preventive for digestive ulcer
JPS57114520A (en) Antiarteriosclerotic agent
JPS5498339A (en) Carcinostatic agent
JPS5569510A (en) Carcinostatic agent
JPS5462327A (en) Remedy for dna virus infectious disease
JPS5545658A (en) Carcinostatic agent
JPS57114518A (en) Hypotensive agent
JPS5675432A (en) Antitumor agent containing ethyl piperidylacetylaminobenzoate